Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
Key Points
Key points are not available for this paper at this time.
Abstract
Swedish Cancer Society, Confederation of Regional Cancer Centres, and Swedish governmental funding for clinical research.
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study | Synapse